<DOC>
	<DOCNO>NCT00303056</DOCNO>
	<brief_summary>The primary objective compare overall treatment effect pain relief icatibant placebo . The secondary objective assess efficacy icatibant term onset , extent duration pain relief relative triamcinolone , evaluate safety icatibant , evaluate overall condition daily life treatment icatibant , assess systemic exposure icatibant follow intra-articular injection .</brief_summary>
	<brief_title>Efficacy Safety Study Intra-articular Multiple Doses Icatibant Patients With Painful Knee Osteoarthritis</brief_title>
	<detailed_description>This multinational , randomize , placebo-controlled study conduct Europe US . Study medication administer intra-articular injection 3 time weekly interval , follow observation period 11 week .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Joint Diseases</mesh_term>
	<mesh_term>Icatibant</mesh_term>
	<mesh_term>Bradykinin</mesh_term>
	<criteria>Male female subject painful osteoarthritis knee . Subjects present diagnosis OA &lt; 3 month OA grade &lt; K &amp; L grade II , condition impact target indication , testcompoundrelated condition , studyrelated condition ( condition detailled CSP ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>knee</keyword>
</DOC>